• 12 FEB 13
    • 4
    Curriculum Vitae

    Curriculum Vitae

    ED J. HENDRICKS, MD, FASBP

    Education

    * B.A.  Rice University, Houston, Texas

    * M.D.  College of Physicians & Surgeons, Columbia University, New York City

    Postgraduate Training

    * Internal Medicine, University of Texas Southwestern Medical School

    & Parkland Hospital, Dallas, Texas

    * Clinical and Anatomical Pathology, University of Minnesota Medical

    School & Hospital, Minneapolis, Minnesota

    Honors

    * Full Tuition Scholarship, Rice University

    * Phi Beta Kappa, Rice University

    * Dean’s Scholarship, College of Physicians & Surgeons, Columbia University

    * NIH Fellowship, University of Minnesota

    * Bariatric Physician of the Year, 2009, American Society of Bariatric Physicians

    * Fellow, American Society of Bariatric Physicians, 2010

    * Vernon B. Astler Award, American Society of Bariatric Physicians, 2011

    Board Certifications

    * American Board of Obesity Medicine, (formerly Amer. Board Bariatric Medicine)

    * American Board of Pathology, Clinical & Anatomic Pathology

    Medical Licensure

    California 

    Experience

    * Pathologist, U.S. Air Force Hospital, Anchorage, Alaska, 1966-1969

    * Associate Pathologist, St. Joseph Hospital, Houston, Texas, 1969-1972

    * Chief Pathologist & Laboratory Director, Fresno Community Hospital,

    Fresno, California, 1972-1986

    * Private Pathology Practice, Fresno, California, 1986-1988

    * Associate Pathologist, Mercy San Juan & Mercy Folsom Hospitals, Carmichael

    & Folsom, California, 1988-1989

    * Medical Director, Center for Weight Management, Roseville & Sacramento California,

    1989 – Present

    Of Note

    * Ex-Officio Trustee, Board of Directors, American Society of Bariatric Physicians, 2012

    * Trustee, Board of Directors, American Society of Bariatric Physicians, 2008 – 2010

    * Trustee, Board of Directors, American Board of Bariatric Medicine, 2000 – 2007

    * Secretary-Treasurer, American Board of Bariatric Medicine, 2002 – 2007

    * FDA Endocrine and Metabolic Drug Advisory Committee, 2010, 2011, 2012-2015

    Memberships

    * American Society of Bariatric Physicians (ASBP)

    * The Obesity Society (TOS, aka North American Society for the Study of Obesity)

    * Fellow, College of American Pathologists (inactive)

    * Fellow, American Society of Clinical Pathologists (inactive)

    * California Society of Pathologists (inactive)

    Hospital Medical Staff Memberships (all past)

    U.S.A.F. Hospital Elmendorf, Anchorage

    St. Joseph Hospital, Houston

    Fresno Community Hospital, Fresno

    Clovis Community Hospital, Clovis

    Veterans Administration Hospital Consultant, Fresno

    Tulare County Hospital, Visalia

    Mercy San Juan Hospital, Carmichael

    Mercy Folsom Hospital, Folsom

    Roseville Hospital, Roseville

    Continuing Medical Education (recent only)

    Obesity Society Annual Scientific Meeting, San Antonio, 2012

    American Society of Bariatric Physicians Annual Seminar, Orlando, 2012

    American Society of Bariatric Physicians and Metabolism Society, Denver, 2012

    Obesity Society Annual Scientific Meeting, Orlando, 2011

    American Society of Bariatric Physicians Annual Seminar, Las Vegas, 2011

    Obesity Society Annual Scientific Meeting, San Diego, CA  2010

    American Society of Bariatric Physicians Annual Seminar, New Orleans, 2010

    Obesity Society Annual Scientific Meeting, Washington, DC, 2009

    American Society of Bariatric Physicians Annual Seminar, Costa Mesa, 2009

    American Society of Bariatric Physicians and Metabolism Society, Charleston, 2009

    American Society of Bariatric Physicians Annual Seminar, Tampa, 2008

    Obesity Society (NAASO), Annual Scientific Meeting, Phoenix, 2008

    American Society of Bariatric Physicians Spring Meeting, Phoenix, 2008

    American Society of Bariatric Physicians Annual Seminar, Las Vegas, 2007

    Obesity Society (NAASO), Annual Scientific Meeting, New Orleans, 2007

    American Society of Bariatric Physicians Spring Meeting, Nashville, 2007

    American Board of Bariatric Medicine, Annual Review Course, Nashville, 2007

    American Society of Bariatric Physicians Annual Seminar, San Diego, 2006

    Obesity Society (NAASO), Annual Scientific Meeting, Boston, 2006

    American Society of Bariatric Physicians Spring Meeting, Louisville, 2006

    American Board of Bariatric Medicine, Annual Review Course, Louisville, 2006

    American Society of Bariatric Physicians Annual Seminar, Las Vegas, 2005

    Obesity Society (NAASO), Annual Scientific Meeting, Vancouver, B.C., 2005

    American Society of Bariatric Physicians Spring Meeting, Atlanta, 2005

    American Board of Bariatric Medicine, Annual Review Course, Atlanta, 2005

    Obesity Society (NAASO), Annual Scientific Meeting, Las Vegas, 2004

    American Society of Bariatric Physicians Spring Meeting, Scottsdale, 2004

    American Society of Bariatric Physicians Annual Seminar, Chicago, 2003

    American Society of Bariatric Physicians Spring Meeting, Las Vegas, 2003

    Papers Published or Presented

    1.         Hendricks, E.J. Trends in U.S.A. Obesity Treatment. in Panbesy Asian Conference Tour (Eurodrug Laboratories, Chinese University of Hong Kong Medical School, , 2012, March 9).

    2.         Hendricks, E.J. Treatment of Obesity in the post-Sibutramine Era. What Are the Options? in Panbesy Asia Conference Tour (Eurodrug Laboratories, Seoul, Korea, 2012, March 7&8).

    3.         Hendricks, E.J. Treatment of Obesity in the post-SIbutramine Era. What are the Options? in Panbesy Asia Conference Tour (Eurodrug Laboratories, Singapore, 2012, March 3).

    4.         Schmidt, S.L. & Hendricks, E.J. The Use of Pharmacotherapy for Obesity Treatment in the United States. in 62nd Annual Obesity and Related Disorders Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).

    5.         Hendricks, E.J. & Rothman, R.B. Phentermine therapy for obesity does not elevate blood pressure. Diabetes, Obesity and Metabolism 13, 963-964 (2012).

    6.         Hendricks, E.J., Greenway, F., Srisurapanont, M., Hendricks, M.J. & De Marco, D. Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Amphetamine-like Phentermine Dependence, Cravings, or Withdrawal. in 62nd Annual Obesity and Related Disorders Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).

    7.         Hendricks, E.J., Greenway, F., Srisurapanont, M., DeMarco, D. & Hendricks, M.J. Long-term Phentermine Does Not Induce Amphetamine-like Dependence. in 62nd Annual Obesity and Related Diseases Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).

    8.         Hendricks, E.J., Greenway, F., Srisurapanont, M., De Marco, D. & Hendricks, M.J. Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal. in NCT01402674 (ed. Clinicaltrials.gov) (Center for Weight Management, Sacramento, 2012).

    9.         Hendricks, E.J. Using Phentermine, Topiramate, & Qsymia. in 62nd Annual Obesity and Related Disorders Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).

    10.       Hendricks, E.J. Two Addiction Medicine Studies in Patients treated with phentermine long-term in 62nd Annual Obesity and Related Conditions Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).

    11.       Hendricks, E.J. Cardiovascular Outcomes Trials for New Obesity Drugs. in 62nd Annual Obesity and Related Conditions Symposium of the American Society Bariatric Physicians (ed. ASBP) (Orlando, 2012).

    12.       Hendricks, E.J. Letter by Hendricks Regarding Article, “Obesity and Cardiovascular Disease”. Circulation 126, e191 (2012).

    13.       Hendricks, E.J. & Rothman, R.B. RE: Pulmonary Hypertension Associated with Use of Phentermine? Yonsei Med J 52, 869-870 (2011).

    14.       Hendricks, E.J. & Rothman, R.B. The Case of Posterior Reversible Encephalopathy with Intracranial Hemorrhage Was Likely Due to Uncontrolled Hypertension, And Was Unrelated and Coincidental to Long-term Phentermine Use. Neurologist Manuscript NRL-11-61 under editorial review(2011).

    15.       Hendricks, E.J., Greenway, F.L., Westman, E.C. & Gupta, A.K. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity (Silver Spring) 19, 2351-2360 (2011).

    16.       Hendricks, E.J. & Greenway, F.L. A Study of Abrupt Phentermine Cessation in Patients in a Weight Management Program. American Journal of Therapeutics 18, 292-299 (2011).

    17.       Hendricks, E.J. Should the FDA approval process for weight-loss drugs be modified? Am J Health Syst Pharm 68, 2094-2095 (2011).

    18.       Hendricks, E.J. Rhabdomyolysis and phentermine: Coincidence, not causation. Am J Health Syst Pharm 68, 1386-1395 (2011).

    19.       Rothman, R.B. & Hendricks, E.J. Phentermine cardiovascular safety. In response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine. International journal of cardiology 2006;106:262-3. Int J Cardiol 144, 241-242; author reply 242-243 (2010).

    20.       Rothman, R.B. & Hendricks, E.J. Phentermine cardiovascular safety II: Response to Yosefy Int J Cardiol. 2009 Epub Mar 19. Int J Cardiol (2010).

    21.       Hendricks, E.J., Greenway, F., Westman, E. & Gupta, A.K. Phentermine pharmacotherapy for Weight Management in Overweight to Morbidly Obese Subjects does not alter seated resting office blood pressure 475P Obesity 18, S2, S151 (2010).

    22.       Hendricks, E.J. Long-term Phentermine: Weight Loss, Blood Pressure, & Heart Rate Effects. in American Society Bariatric Physicians 60th Annual Obesity Seminar (New Orleans, 2010).

    23.       Hendricks, E.J. Chapter 8: Pharmcotherapy. in Obesity: Evaluation and Treatment Essentials (eds. Steelman, G.M. & Westman, E.) 81-99 (Informa Healthcare, New York, New York, 2010).

    24.       Rothman, R.B. & Hendricks, E.J. Phentermine Cardiovascular Safety. American Journal of Emergency Medicine 27, 1010-1013 (2009).

    25.       Hendricks, E.J., Rothman, R.B. & Greenway, F.L. How Physician Obesity Specialists Use Drugs to Treat Obesity. Obesity 17, 1730-1735 (2009).

    26.       Hendricks, E.J. & Greenway, F.L. Symptoms Observed after Abrupt Phentermine Cessation 223-P. Obesity 17, S111 (2009).

    27.       Hendricks, E.J. & Greenway, F.L. Symptoms Observed after Abrupt Phentermine Cessation. in 27th Annual Scientific Meeting (The Obesity Society, Washington, D.C., 2009).

    28.       Hendricks, E.J. Is Phentermine Addicting? in 59th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, Costa Mesa, 2009).

    29.       Hendricks, E.J. & Westman, E.C. Phentermine Therapy in Obesity Treatment: Effect on Blood Pressure 582P. Obesity 16, Supplement 1, S216 (2008).

    30.       Hendricks, E.J., et al. A Survey of Prescribing Practices of Medical Bariatricians. Obesity 16, S292-293 (2008).

    31.       Hendricks, E.J. Adverse Reactions to Phentermine, Evidence versus Conjecture. in 58th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, Tampa, FL, 2008).

    32.       Hendricks, E.J. ASBP Membership Survey of Prescribing Practices. in 58th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, Tampa, Florida, 2008).

    33.       Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (Nashville, TN, 2007).

    34.       Hendricks, E.J. “Indications for Phentermine Use in Treating Obesity: Re-examination of Current Guidelines”. in Eastern Regional Obesity Course, American Society of Bariatric Physicians (Nashville, TN, 2007).

    35.       Hendricks, E.J. “Using the Web to Stay Current with Obesity Treatment and Research”. in 56th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, San Diego, CA, 2006).

    36.       Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (American Board of Bariatric Medicine, Lexington, KY, 2006).

    37.       Hendricks, E.J. Weight Control Pharmacology in Bariatric Surgical Practice. in Bariatric Times, Vol. 3 1,16-19 (2006).

    38.       Hendricks, E.J., Bryman, D. A., Roldan, E. O. Insurance Panel Debate: Pros and Cons. in 55th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, Las Vegas, 2005).

    39.       Hendricks, E.J. “New Obesity Drugs: Current Status Report”. in Eastern Regional Obesity Course, American Society of Bariatric Physicians (Atlanta, GA, 2005).

    40.       Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (American Board of Bariatric Medicine, Atlanta, GA, 2005).

    41.       Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (Scottsdale, AZ, 2004).

    42.       Hendricks, E.J. “Pathophysiology of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (Scottsdale, AZ, 2004).

    43.       Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board Bariatric Medicine (Las Vegas, NV., 2003).

    44.       Hendricks, E.J. “New Bariatric Drugs”. in Western Regional Obesity Course, American Society Bariatric Physicians (Las Vegas, NV, 2003).

    45.       Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board Bariatric Medicine (Denver, CO, 2002).

    46.       Hendricks, E.J. “Pathophysiology of Obesity”. in Basic Bariatric Course, American Society Bariatric Physicians (Boston, MA, 2002).

    47.       Hendricks, E.J. New Drugs for Obesity: Drugs in Phase 2 Clinical Trials. American Journal Bariatric Medicine 17, 17- (2002).

    48.       Hendricks, E.J. New Drugs for Obesity: Drugs in Phase 1 Clinical Trials. American Journal Bariatric Medicine 17, 16- (2002).

    49.       Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board Bariatric Medicine (Atlanta, GA, 2001).

    50.       Hendricks, E.J. “New Drugs on the Horizon”. in 51st Annual Obesity & Associated Conditions Symposium, American Society Bariatric Physicians (San Diego, CA, 2001).

    51.       Hendricks, E.J. New Drugs for Obesity: Drugs in Phase 3 Clinical Trials. American Journal Bariatric Medicine 16, 15- (2001).

    52.       Hendricks, E.J. Laboratory computers: tools for increased productivity. Clin Lab Med 5, 709-723 (1985).

    53.       Chen, K.T. & Hendricks, E.J. Malakoplakia of the female genital tract. Obstet Gynecol 65, 84S-87S (1985).

    54.       Hendricks, E.J. & Langhofer, L.A. A community hospital laboratory computer system: an eight-year longitudinal study of economic impact. Am J Clin Pathol 77, 297-304 (1982).

    55.       Chen, K.T., Hendricks, E.J. & Freeburg, B. Benign glandular inclusion of the peritoneum associated with leiomyomatosis peritonealis disseminata. Diagn Gynecol Obstet 4, 41-44 (1982).

    56.       Hendricks, E.J. “The Computerized Laboratory of the Future”. in Symposium on Clinical Decision Making and Laboratory Use, Riyadh-Al-Karj Hospital (Riyadh, Saudi Arabia, 1981).

    57.       Chen, K.T., Hoffman, K.D. & Hendricks, E.J. Angiosarcoma following therapeutic irradiation. Cancer 44, 2044-2048 (1979).

    58.       Hendricks, E.J. “Mechanisms of Subspecialty Training: Where -University or Private Hospital”. in Symposium on the Future of Graduate Medical Education in Pathology, American Society Clinical Pathologists (Monterey, CA, 1976).

    59.       Hendricks, E.J. “How Should the Pathologist be Trained  to Fulfill His Clinical Role?”. in Symposium on the Future of Graduate Medical Education in Pathology, American Society Clinical Pathologists (Monterey, CA, 1976).

    60.       Simon, R.G., Langhofer, L.A., Jr. & Hendricks, E.J. Australia Antigen Content of Commercial Quality-Control Sera. Clin Chem 19, 221-222 (1973).

    61.       Hendricks, E.J. “Use of Amniotic Fluid Analysis in Prenatal Management of Rh Disease”. in Annual Meeting, Texas Medical Association (Houston, Texas, 1972).

    62.       Hendricks, E.J. Quality control in transition; use of computers in the laboratory. Postgrad Med 44, 67-69 (1968).

    63.       Hendricks, E.J. Methods of blood glucose determination. Postgrad Med 42, A46 passim (1967).

    64.       Hendricks, E. Laboratory Tests of Anterior Pituitary Function. Postgrad Med 37, A44-52 (1965).

    Research in Progress

    1.         Hendricks, E.J., Greenway, F., Srisurapanont, M., De Marco, D. & Hendricks, M.J. Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal. NCT01402674 at Clinicaltrials.gov; An investigation in progress at Center for Weight Management, Sacramento, 2012.

    2.         Hendricks, E.J., Greenway, F., Srisurapanont, M., Hendricks, M.J. & De Marco, D. Psychometric Scale Addiction Metrics During Long-term Phentermine Treatment for Obesity. An investigation in progress at Center for Weight Management, Sacramento, 2012.

    Disclosures

    I have served as a speaker for:

    Eurodrug Laboratories B.V., The Hauge, Netherlands.

    Akrimax Pharmaceuticals, Cranford, New Jersey.

    I have consulted for:

    Citius Pharmaceuticals, Maynard, Massachusetts.

    Rodman & Renshaw, LLC, New York, New York

    GLG Research, Austin Texas

    Credit Suisse, New York, New York

    I have served as expert witness for:

    John H. Cotton & Associates, Las Vegas, Nevada.

    Oliver Maner, LLP, Savannah, Georgia.

    Naulty, Scaricamazza & McDevitt, LLC, Philadelphia, Pennsylvania.

    Kane, Pugh, Knoell, Troy & Kramer, LLP, Norristown, Pennsylvania.

    Smith & Taylor, Henderson, Nevada.

    Silverman, Decaria & Kattleman, Reno, Nevada.

    Steven Hillyard, Inc., San Francisco, California

    Saber Attorneys at Law, Florham Park, New Jersey

    Leave a reply →

Leave a reply

Cancel reply